Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals

NCT01262846 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01262846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01262846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2011
Enrollment
195 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection